{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:01:07Z","timestamp":1740139267548,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Natural Science Fund for Distinguished Young Scholars of Hebei Normal University","award":["No. L2017J04"],"award-info":[{"award-number":["No. L2017J04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10930-020-09952-7","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T20:14:20Z","timestamp":1610741660000},"page":"119-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploration of Serum Marker Proteins in Mice Induced by Babesia microti Infection Using a Quantitative Proteomic Approach"],"prefix":"10.1007","volume":"40","author":[{"given":"Xiaoshuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuguang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0272-0015","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"9952_CR1","doi-asserted-by":"publisher","first-page":"e1003387","DOI":"10.1371\/journal.ppat.1003387","volume":"9","author":"CA Lobo","year":"2013","unstructured":"Lobo CA, Cursino-Santos JR, Alhassan A, Rodrigues M (2013) Babesia: an emerging infectious threat in transfusion medicine. PLoS Pathog 9:e1003387. https:\/\/doi.org\/10.1371\/journal.ppat.1003387","journal-title":"PLoS Pathog"},{"key":"9952_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.idc.2015.02.008","volume":"29","author":"EG Vannier","year":"2015","unstructured":"Vannier EG, Diuk-Wasser MA, Ben Mamoun C, Krause PJ (2015) Babesiosis. Infect Dis Clin North Am 29:357\u2013370. https:\/\/doi.org\/10.1016\/j.idc.2015.02.008","journal-title":"Infect Dis Clin North Am"},{"key":"9952_CR3","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMra1202018","volume":"366","author":"E Vannier","year":"2012","unstructured":"Vannier E, Krause PJ (2012) Human babesiosis. N Engl J Med 366:2397\u20132407. https:\/\/doi.org\/10.1056\/NEJMra1202018","journal-title":"N Engl J Med"},{"key":"9952_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1746-6148-10-111","volume":"10","author":"J Kules","year":"2014","unstructured":"Kules J, Mrljak V, Baric Rafaj R, Selanec J, Burchmore R, Eckersall PD (2014) Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach. BMC Vet Res 10:111. https:\/\/doi.org\/10.1186\/1746-6148-10-111","journal-title":"BMC Vet Res"},{"key":"9952_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/omi.2012.0037","volume":"16","author":"S Ray","year":"2012","unstructured":"Ray S, Srivastava R, Tripathi K, Vaibhav V, Patankar S, Srivastava S (2012) Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets? OMICS 16:527\u2013536. https:\/\/doi.org\/10.1089\/omi.2012.0037","journal-title":"OMICS"},{"key":"9952_CR6","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13071-018-2951-0","volume":"11","author":"B Xu","year":"2018","unstructured":"Xu B, Liu XF, Cai YC, Huang JL, Zhang RX, Chen JH, Cheng XJ, Zhou X, Xu XN, Zhou Y, Zhang T, Chen SB, Li J, Wu QF, Sun CS, Fu YF, Chen JX, Zhou XN, Hu W (2018) Screening for biomarkers reflecting the progression of Babesia microti infection. Parasites Vectors 11:379. https:\/\/doi.org\/10.1186\/s13071-018-2951-0","journal-title":"Parasites Vectors"},{"key":"9952_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10493-020-00469-3","volume":"80","author":"M Wang","year":"2020","unstructured":"Wang M, Hu Y, Li M, Xu Q, Zhang X, Wang X, Xue X, Xiao Q, Liu J, Wang H (2020) A proteomics analysis of the ovarian development in females of Haemaphysalis longicornis. Exp Appl Acarol 80:289\u2013309. https:\/\/doi.org\/10.1007\/s10493-020-00469-3","journal-title":"Exp Appl Acarol"},{"key":"9952_CR8","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu SF, Yang CY, Bai MZ, Shu KX, Li KL, Zhang GQ, Jin Z, He FC, Hermjakob H, Zhu YP (2019) iProX: an integrated proteome resource. Nucleic Acids Res 47:D1211\u2013D1217. https:\/\/doi.org\/10.1093\/nar\/gky869","journal-title":"Nucleic Acids Res"},{"key":"9952_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jcrc.2014.12.009","volume":"30","author":"JY Jung","year":"2015","unstructured":"Jung JY, Kwak YH, Kim KS, Kwon WY, Suh GJ (2015) Change of hemopexin level is associated with the severity of sepsis in endotoxemic rat model and the outcome of septic patients. J Crit Care 30:525\u2013530. https:\/\/doi.org\/10.1016\/j.jcrc.2014.12.009","journal-title":"J Crit Care"},{"key":"9952_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/STROKEAHA.115.011956","volume":"47","author":"P Garland","year":"2016","unstructured":"Garland P, Durnford AJ, Okemefuna AI, Dunbar J, Nicoll JA, Galea J, Boche D, Bulters DO, Galea I (2016) Heme-hemopexin scavenging is active in the brain and associates with outcome after subarachnoid hemorrhage. Stroke 47:872\u2013876. https:\/\/doi.org\/10.1161\/STROKEAHA.115.011956","journal-title":"Stroke"},{"key":"9952_CR11","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1128\/JCM.39.6.2178-2183.2001","volume":"39","author":"Q Wei","year":"2001","unstructured":"Wei Q, Tsuji M, Zamoto A, Kohsaki M, Matsui T, Shiota T, Telford SR, Ishihara C (2001) Human babesiosis in Japan: isolation of Babesia microti-like parasites from an asymptomatic transfusion donor and from a rodent from an area where babesiosis is endemic. J Clin Microbiol 39:2178\u20132183. https:\/\/doi.org\/10.1128\/JCM.39.6.2178-2183.2001","journal-title":"J Clin Microbiol"},{"key":"9952_CR12","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1110","volume":"3","author":"K Honey","year":"2003","unstructured":"Honey K, Rudensky AY (2003) Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 3:472\u2013482. https:\/\/doi.org\/10.1038\/nri1110","journal-title":"Nat Rev Immunol"},{"key":"9952_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prca.201300105","volume":"8","author":"N Aggarwal","year":"2014","unstructured":"Aggarwal N, Sloane BF (2014) Cathepsin B: multiple roles in cancer. Proteomics Clin Appl 8:427\u2013437. https:\/\/doi.org\/10.1002\/prca.201300105","journal-title":"Proteomics Clin Appl"},{"key":"9952_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1568016043356327","volume":"2","author":"NH Choi-Miura","year":"2004","unstructured":"Choi-Miura NH (2004) Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans. Curr Med Chem Cardiovasc Hematol Agents 2:239\u2013248. https:\/\/doi.org\/10.2174\/1568016043356327","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"9952_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/03008200802325458","volume":"49","author":"L Zhuo","year":"2008","unstructured":"Zhuo L, Kimata K (2008) Structure and function of inter-alpha-trypsin inhibitor heavy chains. Connect Tissue Res 49:311\u2013320. https:\/\/doi.org\/10.1080\/03008200802325458","journal-title":"Connect Tissue Res"},{"key":"9952_CR16","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.15252\/embj.201591881","volume":"34","author":"G Bajic","year":"2015","unstructured":"Bajic G, Degn SE, Thiel S, Andersen GR (2015) Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J 34:2735\u20132757. https:\/\/doi.org\/10.15252\/embj.201591881","journal-title":"EMBO J"},{"key":"9952_CR17","doi-asserted-by":"publisher","first-page":"47s","DOI":"10.1111\/1523-1747.ep12275445","volume":"85","author":"HJ Muller-Eberhard","year":"1985","unstructured":"Muller-Eberhard HJ (1985) The killer molecule of complement. J Investig Dermatol 85:47s\u201352s. https:\/\/doi.org\/10.1111\/1523-1747.ep12275445","journal-title":"J Investig Dermatol"},{"key":"9952_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/eci.12798","volume":"47","author":"F Ursini","year":"2017","unstructured":"Ursini F, Russo E, Mauro D, Abenavoli L, Ammerata G, Serrao A, Grembiale RD, De Sarro G, Olivieri I, D\u2019Angelo S (2017) Complement C3 and fatty liver disease in rheumatoid arthritis patients: a cross-sectional study. Eur J Clin Investig 47:728\u2013735. https:\/\/doi.org\/10.1111\/eci.12798","journal-title":"Eur J Clin Investig"},{"key":"9952_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3409\/fb62_4.353","volume":"62","author":"H Okla","year":"2014","unstructured":"Okla H, Jasik KP, Slodki J, Rozwadowska B, Slodki A, Jurzak M, Pierzchala E (2014) Hepatic tissue changes in rats due to chronic invasion of Babesia microti. Folia Biol (Krakow) 62:353\u2013359. https:\/\/doi.org\/10.3409\/fb62_4.353","journal-title":"Folia Biol (Krakow)"},{"key":"9952_CR20","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1073\/pnas.72.8.3220","volume":"72","author":"DT Fearon","year":"1975","unstructured":"Fearon DT, Austen KF (1975) Properdin: initiation of alternative complement pathway. Proc Natl Acad Sci USA 72:3220\u20133224. https:\/\/doi.org\/10.1073\/pnas.72.8.3220","journal-title":"Proc Natl Acad Sci USA"},{"key":"9952_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/imr.12466","volume":"274","author":"AZ Blatt","year":"2016","unstructured":"Blatt AZ, Pathan S, Ferreira VP (2016) Properdin: a tightly regulated critical inflammatory modulator. Immunol Rev 274:172\u2013190. https:\/\/doi.org\/10.1111\/imr.12466","journal-title":"Immunol Rev"},{"key":"9952_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184\u2013192. https:\/\/doi.org\/10.1016\/j.it.2007.02.006","journal-title":"Trends Immunol"},{"key":"9952_CR23","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","volume":"177","author":"K Ritis","year":"2006","unstructured":"Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177:4794\u20134802. https:\/\/doi.org\/10.4049\/jimmunol.177.7.4794","journal-title":"J Immunol"},{"key":"9952_CR24","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1681\/ASN.2017121244","volume":"29","author":"Y Ueda","year":"2018","unstructured":"Ueda Y, Miwa T, Gullipalli D, Sato S, Ito D, Kim H, Palmer M, Song WC (2018) Blocking properdin prevents complement-mediated hemolytic uremic syndrome and systemic thrombophilia. J Am Soc Nephrol 29:1928\u20131937. https:\/\/doi.org\/10.1681\/ASN.2017121244","journal-title":"J Am Soc Nephrol"},{"key":"9952_CR25","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1172\/jci41782","volume":"120","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, Zhou L, Miwa T, Song WC (2010) Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury. J Clin Investig 120:3545\u20133554. https:\/\/doi.org\/10.1172\/jci41782","journal-title":"J Clin Investig"},{"key":"9952_CR26","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.4049\/jimmunol.1202275","volume":"190","author":"T Miwa","year":"2013","unstructured":"Miwa T, Sato S, Gullipalli D, Nangaku M, Song WC (2013) Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. J Immunol 190:3552\u20133559. https:\/\/doi.org\/10.4049\/jimmunol.1202275","journal-title":"J Immunol"},{"key":"9952_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.4049\/jimmunol.1401819","volume":"195","author":"Y Wang","year":"2015","unstructured":"Wang Y, Miwa T, Ducka-Kokalari B, Redai IG, Sato S, Gullipalli D, Zangrilli JG, Haczku A, Song WC (2015) Properdin contributes to allergic airway inflammation through local C3a generation. J Immunol 195:1171\u20131181. https:\/\/doi.org\/10.4049\/jimmunol.1401819","journal-title":"J Immunol"},{"key":"9952_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1172\/JCI107967","volume":"55","author":"PC Harpel","year":"1975","unstructured":"Harpel PC, Cooper NR (1975) Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin. J Clin Investig 55:593\u2013604. https:\/\/doi.org\/10.1172\/JCI107967","journal-title":"J Clin Investig"},{"key":"9952_CR29","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.4049\/jimmunol.165.5.2637","volume":"165","author":"M Matsushita","year":"2000","unstructured":"Matsushita M, Thiel S, Jensenius JC, Terai I, Fujita T (2000) Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol 165:2637\u20132642. https:\/\/doi.org\/10.4049\/jimmunol.165.5.2637","journal-title":"J Immunol"},{"key":"9952_CR30","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI111360","volume":"73","author":"A de Agostini","year":"1984","unstructured":"de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M (1984) Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Investig 73:1542\u20131549. https:\/\/doi.org\/10.1172\/JCI111360","journal-title":"J Clin Investig"},{"key":"9952_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/ATVBAHA.116.308595","volume":"37","author":"KF Nickel","year":"2017","unstructured":"Nickel KF, Long AT, Fuchs TA, Butler LM, Renne T (2017) Factor XII as a therapeutic target in thromboembolic and inflammatory diseases. Arterioscler Thromb Vasc Biol 37:13\u201320. https:\/\/doi.org\/10.1161\/ATVBAHA.116.308595","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9952_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","volume":"51","author":"AD Marais","year":"2019","unstructured":"Marais AD (2019) Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. Pathology 51:165\u2013176. https:\/\/doi.org\/10.1016\/j.pathol.2018.11.002","journal-title":"Pathology"},{"key":"9952_CR33","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1172\/JCI118098","volume":"96","author":"WA Boisvert","year":"1995","unstructured":"Boisvert WA, Spangenberg J, Curtiss LK (1995) Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Investig 96:1118\u20131124. https:\/\/doi.org\/10.1172\/JCI118098","journal-title":"J Clin Investig"},{"key":"9952_CR34","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1172\/JCI112713","volume":"78","author":"HN Ginsberg","year":"1986","unstructured":"Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Investig 78:1287\u20131295. https:\/\/doi.org\/10.1172\/JCI112713","journal-title":"J Clin Investig"},{"key":"9952_CR35","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1172\/JCI116066","volume":"90","author":"K Aalto-Setala","year":"1992","unstructured":"Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Investig 90:1889\u20131900. https:\/\/doi.org\/10.1172\/JCI116066","journal-title":"J Clin Investig"},{"key":"9952_CR36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.atv.15.7.963","volume":"15","author":"V Clavey","year":"1995","unstructured":"Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC (1995) Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 15:963\u2013971. https:\/\/doi.org\/10.1161\/01.atv.15.7.963","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9952_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/CIRCRESAHA.110.219188","volume":"107","author":"RJ Brown","year":"2010","unstructured":"Brown RJ, Lagor WR, Sankaranaravanan S, Yasuda T, Quertermous T, Rothblat GH, Rader DJ (2010) Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins. Circ Res 107:357\u2013364. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.219188","journal-title":"Circ Res"},{"key":"9952_CR38","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.2337\/dc08-0358","volume":"31","author":"EM Ooi","year":"2008","unstructured":"Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH (2008) Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care 31:1656\u20131661. https:\/\/doi.org\/10.2337\/dc08-0358","journal-title":"Diabetes Care"},{"key":"9952_CR39","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.111.056986","volume":"124","author":"CO Mendivil","year":"2011","unstructured":"Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM (2011) Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation 124:2065\u20132072. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.056986","journal-title":"Circulation"},{"key":"9952_CR40","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1126\/science.1161524","volume":"322","author":"TI Pollin","year":"2008","unstructured":"Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O\u2019Connell JR, Shuldiner AR (2008) A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322:1702\u20131705. https:\/\/doi.org\/10.1126\/science.1161524","journal-title":"Science"},{"key":"9952_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","volume":"371","author":"J Crosby","year":"2014","unstructured":"TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA, Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox S, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O\u2019Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S (2014) Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 371:22\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1307095","journal-title":"N Engl J Med"},{"key":"9952_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/s1388-1981(01)00081-6","volume":"1531","author":"CG Brouillette","year":"2001","unstructured":"Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW (2001) Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 1531:4\u201346. https:\/\/doi.org\/10.1016\/s1388-1981(01)00081-6","journal-title":"Biochim Biophys Acta"},{"key":"9952_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrcardio.2009.94","volume":"6","author":"D Duffy","year":"2009","unstructured":"Duffy D, Rader DJ (2009) Update on strategies to increase HDL quantity and function. Nat Rev Cardiol 6:455\u2013463. https:\/\/doi.org\/10.1038\/nrcardio.2009.94","journal-title":"Nat Rev Cardiol"},{"key":"9952_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-2362.2006.01737.x","volume":"36","author":"KH Cho","year":"2006","unstructured":"Cho KH, Park SH, Han JM, Kim HC, Choi YK, Choi I (2006) ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities. Eur J Clin Investig 36:875\u2013882. https:\/\/doi.org\/10.1111\/j.1365-2362.2006.01737.x","journal-title":"Eur J Clin Investig"},{"key":"9952_CR45","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/gerona\/glr169","volume":"66","author":"KH Cho","year":"2011","unstructured":"Cho KH (2011) Enhanced delivery of rapamycin by V156K-apoA-I high-density lipoprotein inhibits cellular proatherogenic effects and senescence and promotes tissue regeneration. J Gerontol A Biol Sci Med Sci 66:1274\u20131285. https:\/\/doi.org\/10.1093\/gerona\/glr169","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"9952_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0009-3084(01)00201-8","volume":"114","author":"G Ferretti","year":"2002","unstructured":"Ferretti G, Bacchetti T, Bicchiega V, Curatola G (2002) Effect of human Apo AIV against lipid peroxidation of very low density lipoproteins. Chem Phys Lipids 114:45\u201354. https:\/\/doi.org\/10.1016\/s0009-3084(01)00201-8","journal-title":"Chem Phys Lipids"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-020-09952-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-020-09952-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-020-09952-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:30:24Z","timestamp":1667521824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-020-09952-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["9952"],"URL":"https:\/\/doi.org\/10.1007\/s10930-020-09952-7","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"type":"print","value":"1572-3887"},{"type":"electronic","value":"1875-8355"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"16 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}